InternationalUSRemember you can easily switch between MIP US and MIP International at any time

MIP International Patent Forum 2016 - Agenda

March 9 & 10, Hotel Pullman London St Pancras





Contact us

Download the brochure

Programme - day one

08.15 Registration

08:45 Opening remarks from Managing IP and welcome from the chair
James Nurton,
managing editor, Managing IP
Andrew Hammond
, partner, Valea

08:55 Keynote address
Rosa Wilkinson
, director of innovation, UK Intellectual Property Office

09.10 Updates from the European Patent Reform

  • Examining the Unitary Patent and Unified Patent Court
  • What are the implications of the fees on your budget: to opt in or opt out?
  • How will the new reforms impact your IP strategy in Europe?
  • Availability of injunctions under UPC: taking on patent trolls to protect innovation

Mark Chadwick, Senior Patent Attorney, DSM
Colin Lamond,
Patent & IP Consultant, Nissan Technical Centre Europe
Stefan Luginbuehl, 
Lawyer - international legal affairs, European Patent Office
Joachim Feldges,
partner, Allen & Overy
Mark Ridgway,
partner, Allen & Overy

10.00 Licensing in technology, media and telecommunications

  • Considerations for licensing and litigating standard essential products
  • Examining the benefits of patent pools to generate licensing revenue 
  • Identifying the advantages and drawbacks of business models across different jurisdictions 
  • What could the future look like for standards essential patent licensing?

Kerry Miller, Senior IPR Licensing Counsel, Nokia
Daniel Hermele
, Senior Director & Legal Counsel, Qualcomm
Earl Nied, program director of standards and IPR, Intel 
Roberto Dini,
founder, Sisvel
Alexandra Brodie,
partner, Gowling WLG

10.50 Coffee break and networking

11.10 Software patents: Europe versus USA

  • Understanding how the USA is accommodating software patenting decisions and how is the USPTO implementing these decisions?
  • Practical implications of USA software law
  • Comparison of software patenting in US and Europe

Kevin Fournier, Lawyer, IBM
Rosie Stoakes,
Group Head of IP, Glory Global Solutions
Alice Hume,
Global Head of IP, Qlik
Simon Kahn,
partner, Boult Wade Tennant

12.00 Post-grant patent proceedings before USPTO's PTAB

  • Analysing post grant proceedings and PTAB trials: why are so many patents being invalidated?
  • How to manage concerns over how the rules are being interpreted by PTAB
  • Brief comparison with EPO opposition proceedings
  • What does the future hold? USPTO and PTAB statistics

Benjamin Hoffman, European patent attorney, Valea
Brian LaCorte, partner, Ballard Spahr

12.50 Protecting your IP in Russia

  • How will institutional changes in patent protection and enforcement influence IP rights?
  • Examining the pros and cons of the newly established IP courts
  • Strategies to secure strong patent protection in Russia

Natalia Gulyaeva, partner, Hogan Lovells

13.20 Lunch and networking

14.10 Managing your IP in Africa

  • Scope and feasibility of patent searching in selected African jurisdictions
  • Understanding implications and risks of the Madrid system when filing trade marks in major African jurisdictions
  • Recent case law developments impacting on patents, designs and trademarks strategies in South Africa

Dario Tanziani, partner, Adams & Adams
Danie Dohmen, partner, Adams & Adams
Megan Moerdijk,
partner, Adams & Adams
Pieter van den Bulck, group IP counsel, SABMiller

15.00 Industry debate: litigation planning

  • Comparison of strategies between different industries
  • How to select the best litigation strategy for your business
  • Understanding the risks and opportunities of forum shopping

David Por, partner, Allen & Overy
Pankaj Soni, partner, Remfry & Sagar
Clemens Heusch, Head of European Litigation, Nokia
Neil Trueman
, Director of European IP Strategy, Mundipharma International

15.50 Coffee break and networking

16.10 Supplementary Protection Certificates: An update

  • The Seattle Genetics CJEU decision (C471/14)
  • The steps you now need to take to gain the additional term provided for by the Seattle case
  • Recent developments on SPCs for combination medicines

Paul Brady, partner, Abel & Imray

16.40 FOCUS: UK Patent Box regime

  • Analysing the updated rules and how this impacts your portfolio
  • Is the use of the Patent Box unfair tax competition?
  • Why you should commercialise your patents: understanding how to take advantage of the scheme

Russell Edson, senior associate, Withers & Rogers

17.10 End of day one and cocktail drinks reception

Programme - day two

08.15 Registration

08:45 Opening remarks from Managing IP
James Nurton,
managing editor, Managing IP
Gordon Harris,
 head of IP, Gowling WLG

08:55 Keynote address
Patrick Kilbride,
executive director, international intellectual property, US Chamber of Commerce

09.10 Patent enforcement strategies

  • Strategies to accelerate your patent applications and ensure enforcement
  • How to achieve patent enforcement in multiple jurisdictions and unfamiliar markets
  • Minimising risk and costs to build a robust patent portfolio
  • Considerations for design patents

Ed Round, partner, Marks & Clerk
Jody Giesser, Senior Patent Counsel, DSM Nutritional Products
Adrian Howes,
senior litigation counsel, Nokia
Charlie Balme, solicitor, Marks & Clerk

10.00 Patentable subject matter: update on Alice v CLS Bank decision

  • Implications of the current draconian environment
  • Examining changes in federal rules of civil procedure
  • What are the alternatives to software protection?
  • Developments in trends over the past 12 months and future predictions

Philip Cupitt, partner, Finnegan
Adam Pilcher, Patent Manager, Metaswitch Networks
Calum Smyth,
Global Head of Intellectual Property, Barclays

10.50 Coffee break and networking

11.10 Examining India’s developing IP landscape

  • How will your business be impacted by a stronger IP regime?
  • India's new specialist IP court: progress report
  • Dealing with IP infringements in India

Pravin Anand, managing partner, Anand & Anand

11.40 Tackling the issues for infringement of second medical use claims

  • Recent case updates from second medical use patents: Lyrica v Pregabalin
  • Assessing direct and indirect infringement of second medical use patents
  • Understanding the requirements for proving infringement and assessing the scope of liability
  • Strategies to take advantage of second medical use patents across multiple jurisdictions

Fiona Bor, Head of IP, Mereo BioPharma
Alpha Indraccolo,
Associate General Counsel, Europe, Teva Europe
Marianne Schaffner
, partner, Dechert

12.10 FOCUS: Turkey

  • Harmonisation of the Turkish Patent Law: an update
  • Examining recent trends in patent litigation in Turkey
  • Drawing comparisons of validity and enforcement of second medical use claims in Turkey and elsewhere

Özge Atilgan Karakulak, partner, Gün + Partners
Selin Sinem Erciyas, partner, Gün + Partners
John Hutchison, patent attorney, Novartis Pharma

12.40 Lunch and networking

13.40 Patent monetisation and commercialisation

  • How to construct a proactive patent monetisation framework that aligns IP strategy with business strategy
  • Patent monetisation versus technical transfer
  • Why you should commercialise your patents: a case study

Lyle Ellis, Senior Patent Attorney, Vodafone
Elli Oxtoby, Group IP Director, QinetiQ
Sarah Turner, partner, Hogan Lovells
Mark Marfe, senior associate, Hogan Lovells

14.30 How to create a strong patent portfolio in the current pro-patentee environment of China

  • Considerations for filing applications in China and creating a strong patent portfolio
  • How to produce the most suitable invention disclosures around a specific technical area
  • Understanding the reasons behind rejections raised by examiners of both SIPO and EPO
  • Strategies to ensure enforceable patent rights in Europe and China

Lulin Gao, chairman, Beijing East IP
Dragon Wang
, vice president, Beijing East IP
David Galaun,
senior patent attorney, Cisco Systems

15.10 Coffee break and networking

15.30 Developments in trade secret protection as a means to protect your IP

  • Harmonisation of trade secrets: Understanding the new proposed European directive
  • How to ensure confidentiality is kept during court proceedings across multiple jurisdictions
  • Technical trade secrets: Should reverse engineering have any restrictions?
  • Patents versus trade secrets

Pete Wilson, senior patent attorney, BT
Carol Arnold,
associate counsel, Shell International
Alice Stagg, senior associate, Gowling WLG
Thomas Farkas
, associate, Gowling WLG

16.10 Close of conference

Lead Sponsor


Abel & Imray
Adams & Adams

Anand and Anand
Beijing East IP
Boult Wade Tennant

Gowling WLG

Hogan Lovells

Marks & Clerk

Remfry & Sagar

Withers & Rogers


Morningside IP
Park IP


Association Partners





India Law Journal

More from the Managing IP blog

null null null



July /August 2019

AI and IP: the view from above

Managing IP speaks to the directors of WIPO and the EUIPO to gauge their views on AI, asking how the technology can help the offices be more efficient and whether job losses are inevitable

Most read articles